妇科千金片联合阿莫西林克拉维酸钾片治疗慢性盆腔炎的临床疗效及安全性评价

发布时间：2018-05-30 06:56

本文选题：妇科千金片 + 阿莫西林克拉维酸钾片　；参考：《辽宁中医杂志》2015年05期

【摘要】：目的:探讨妇科千金片联合阿莫西林克拉维酸钾片治疗慢性盆腔炎的临床疗效及安全性。方法:选择我院收治的慢性盆腔炎患者60例,将其随机分为观察组对照组,每组30例,对照组给予阿莫西林克拉维酸钾片,观察组在对照组基础上加用妇科千金片,两组均连续治疗2周,比较两组临床疗效、各症状评分、盆腔炎性包块改善情况以及不良反应。结果:观察组治疗总有效率为93.33%,对照组治疗总有效率为73.33%,两组比较,差异具统计学意义(P0.05);治疗后,两组患者各临床症状评分均较治疗前显著改善(P0.05),且观察组改善情况显著优于对照组(P0.05);治疗后,两组患者盆腔炎性包块显著较治疗前缩小(P0.05),且观察组治疗后包括显著小于对照组(P0.05);治疗期间,观察组不良反应发生率6.67%、对照组3.33%,两组比较差异不存在统计学意义(P0.05)。结论:妇科千金片联合阿莫西了拉维酸钾片治疗慢性盆腔炎其疗效确切,能够显著改善患者临床症状,并有效缩小盆腔炎性包块,治疗安全可靠,值得临床推广运用。
[Abstract]:Objective: to investigate the clinical efficacy and safety of gynecological Qianjin tablets combined with amoxicillin clavulanate potassium tablets in the treatment of chronic pelvic inflammation. Methods: sixty patients with chronic pelvic inflammatory disease were randomly divided into the control group (n = 30) and the control group (n = 30). The control group was treated with amoxicillin clavulanate potassium tablets, and the observation group was treated with gynecological Qianjin tablet on the basis of the control group. The two groups were treated continuously for 2 weeks. The clinical efficacy, the scores of symptoms, the improvement of pelvic inflammatory mass and the adverse reactions were compared between the two groups. Results: the total effective rate of treatment in the observation group was 93.33 and that in the control group was 73.33. The difference between the two groups was statistically significant (P 0.05). The clinical symptom scores of the two groups were significantly improved compared with those before treatment, and the improvement of the observation group was significantly better than that of the control group (P 0.05). The pelvic inflammatory mass of the two groups was significantly smaller than that before treatment, and the observation group was significantly smaller than that of the control group after treatment. During the treatment period, the incidence of adverse reactions in the observation group was 6.67 and that in the control group was 3.33. The difference between the two groups was not statistically significant (P 0.05). Conclusion: gynecological Qianjin tablet combined with lamivudine potassium lamivudate tablet is effective in the treatment of chronic pelvic inflammatory disease, it can significantly improve the clinical symptoms of the patients, and effectively reduce the pelvic inflammatory mass, the treatment is safe and reliable, worthy of clinical application.
【作者单位】：泰顺县第二人民医院妇产科;浙江大学医学院附属妇产科医院妇产科;
【分类号】：R711.33

【参考文献】